We confirmed in newly-diagnosed M4/5 subtype AML patients that there were increased levels of pro-inflammatory cytokines TNF and IL-1 in their peripheral blood (Figure 3B), which correlated to the increased TNF and IL1 expression by CD34+ tumor cells (Figure 3B). Here, IL1A is linked to acute myeloid leukemia.